Geovax Labs Inc (GOVX)
2.81
+0.11
(+4.07%)
USD |
NASDAQ |
Nov 22, 11:22
Geovax Labs Enterprise Value: 16.88M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 16.88M |
| November 20, 2024 | 16.04M |
| November 19, 2024 | 18.87M |
| November 18, 2024 | 20.00M |
| November 15, 2024 | 14.34M |
| November 14, 2024 | 16.04M |
| November 13, 2024 | 16.88M |
| November 12, 2024 | 22.07M |
| November 11, 2024 | 21.04M |
| November 08, 2024 | 9.808M |
| November 07, 2024 | 9.525M |
| November 06, 2024 | 8.676M |
| November 05, 2024 | 8.581M |
| November 04, 2024 | 8.298M |
| November 01, 2024 | 9.525M |
| October 31, 2024 | 9.997M |
| October 30, 2024 | 8.798M |
| October 29, 2024 | 8.712M |
| October 28, 2024 | 8.54M |
| October 25, 2024 | 9.229M |
| October 24, 2024 | 9.831M |
| October 23, 2024 | 10.78M |
| October 22, 2024 | 9.143M |
| October 21, 2024 | 10.69M |
| October 18, 2024 | 9.659M |
| Date | Value |
|---|---|
| October 17, 2024 | 8.712M |
| October 16, 2024 | 9.487M |
| October 15, 2024 | 9.573M |
| October 14, 2024 | 8.712M |
| October 11, 2024 | 8.884M |
| October 10, 2024 | 8.884M |
| October 09, 2024 | 10.61M |
| October 08, 2024 | 8.454M |
| October 07, 2024 | 8.712M |
| October 04, 2024 | 9.229M |
| October 03, 2024 | 9.487M |
| October 02, 2024 | 9.659M |
| October 01, 2024 | 10.35M |
| September 30, 2024 | 12.16M |
| September 27, 2024 | 19.47M |
| September 26, 2024 | 19.64M |
| September 25, 2024 | 21.17M |
| September 24, 2024 | 22.02M |
| September 23, 2024 | 21.85M |
| September 20, 2024 | 23.73M |
| September 19, 2024 | 21.60M |
| September 18, 2024 | 21.51M |
| September 17, 2024 | 21.85M |
| September 16, 2024 | 21.68M |
| September 13, 2024 | 22.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.59M
Minimum
Jul 22 2022
58.78M
Maximum
Aug 21 2024
3.345M
Average
2.578M
Median
May 01 2024
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.022B |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| Abbott Laboratories | 210.81B |
| SIGA Technologies Inc | 348.44M |
| Chimerix Inc | -54.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.816M |
| Revenue (Quarterly) | 2.790M |
| Total Expenses (Quarterly) | 8.644M |
| EPS Diluted (Quarterly) | -0.91 |
| Profit Margin (Quarterly) | -208.5% |
| Earnings Yield | -328.8% |
| Normalized Earnings Yield | -328.83 |